Theralase Technologies Inc
XTSX:TLT

Watchlist Manager
Theralase Technologies Inc Logo
Theralase Technologies Inc
XTSX:TLT
Watchlist
Price: 0.3 CAD 3.45% Market Closed
Market Cap: 72.8m CAD
Have any thoughts about
Theralase Technologies Inc?
Write Note

Wall Street
Price Targets

TLT Price Targets Summary
Theralase Technologies Inc

Wall Street analysts forecast TLT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TLT is 0.82 CAD with a low forecast of 0.81 CAD and a high forecast of 0.84 CAD.

Lowest
Price Target
0.81 CAD
169% Upside
Average
Price Target
0.82 CAD
172% Upside
Highest
Price Target
0.84 CAD
180% Upside
Theralase Technologies Inc Competitors:
Price Targets
300529
Jafron Biomedical Co Ltd
45% Upside
7575
Japan Lifeline Co Ltd
11% Upside
EW
Edwards Lifesciences Corp
9% Upside
BFLY
Butterfly Network Inc
2% Upside
TMDX
Transmedics Group Inc
77% Upside
PEN
Penumbra Inc
2% Downside
INGN
Inogen Inc
9% Upside
ZIMV
ZimVie Inc
47% Upside

Revenue
Forecast

Revenue Estimate
Theralase Technologies Inc

For the last 8 years the compound annual growth rate for Theralase Technologies Inc's revenue is -7%. The projected CAGR for the next 3 years is 220%.

-7%
Past Growth
220%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Theralase Technologies Inc

Operating Income forecast
is not available for
Theralase Technologies Inc

Net Income
Forecast

Net Income Estimate
Theralase Technologies Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-28%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TLT's stock price target?
Price Target
0.82 CAD

According to Wall Street analysts, the average 1-year price target for TLT is 0.82 CAD with a low forecast of 0.81 CAD and a high forecast of 0.84 CAD.

What is Theralase Technologies Inc's Revenue forecast?
Projected CAGR
220%

For the last 8 years the compound annual growth rate for Theralase Technologies Inc's revenue is -7%. The projected CAGR for the next 3 years is 220%.

Back to Top